GWP
STRO icon

Gen-Wealth Partners’s Sutro Biopharma STRO Stock Holding History

Gen-Wealth Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-404
Closed -$2.89K – 712
2025
Q2 		$2.89K Hold
404
– – ﹤0.01% 545
2025
Q1 		$2.63K Buy
404
+300
+288% +$4.72K ﹤0.01% 535
2024
Q4 		$1.92K Hold
104
– – ﹤0.01% 583
2024
Q3 		$3.71K Hold
104
– – ﹤0.01% 567
2024
Q2 		$3.05K Buy
+104
New +$4.11K ﹤0.01% 562

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Gen-Wealth Partners's STRO Position: Q3 2025 in Review

Gen-Wealth Partners sold out of Sutro Biopharma (STRO) in Q3 2025, closing a stake of 404 shares — an estimated $2.89K sold.

Gen-Wealth Partners first reported a position in STRO in Q2 2024 and held it in 5 quarters. The position peaked at $3.71K in Q3 2024. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • Gen-Wealth Partners reported no remaining Sutro Biopharma position as of Q3 2025 after selling out during the quarter.
  • Gen-Wealth Partners sold 404 Sutro Biopharma shares in Q3 2025, an estimated $2.89K.
  • Gen-Wealth Partners first reported a position in Sutro Biopharma in Q2 2024 and held it in 5 quarters.
  • Gen-Wealth Partners's Sutro Biopharma position peaked at $3.71K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on Gen-Wealth Partners's 13F filing for Q3 2025, filed 14 Nov 2025.